Request for Covid-19 Impact Assessment of this Report
The United States Surgical Hemostatic Agents market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Surgical Hemostatic Agents market, reaching US$ million by the year 2028. As for the Europe Surgical Hemostatic Agents landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Surgical Hemostatic Agents players cover J&J, Baxter, BD, and Gelita, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Surgical Hemostatic Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Gelation Hemostats
Combination Hemostats
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Surgical Centers
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Surgical Hemostatic Agents Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Surgical Hemostatic Agents by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Surgical Hemostatic Agents by Country/Region, 2017, 2022 & 2028
2.2 Surgical Hemostatic Agents Segment by Type
2.2.1 Gelation Hemostats
2.2.2 Combination Hemostats
2.2.3 Others
2.3 Surgical Hemostatic Agents Sales by Type
2.3.1 Global Surgical Hemostatic Agents Sales Market Share by Type (2017-2022)
2.3.2 Global Surgical Hemostatic Agents Revenue and Market Share by Type (2017-2022)
2.3.3 Global Surgical Hemostatic Agents Sale Price by Type (2017-2022)
2.4 Surgical Hemostatic Agents Segment by Application
2.4.1 Hospitals
2.4.2 Surgical Centers
2.4.3 Other
2.5 Surgical Hemostatic Agents Sales by Application
2.5.1 Global Surgical Hemostatic Agents Sale Market Share by Application (2017-2022)
2.5.2 Global Surgical Hemostatic Agents Revenue and Market Share by Application (2017-2022)
2.5.3 Global Surgical Hemostatic Agents Sale Price by Application (2017-2022)
3 Global Surgical Hemostatic Agents by Company
3.1 Global Surgical Hemostatic Agents Breakdown Data by Company
3.1.1 Global Surgical Hemostatic Agents Annual Sales by Company (2020-2022)
3.1.2 Global Surgical Hemostatic Agents Sales Market Share by Company (2020-2022)
3.2 Global Surgical Hemostatic Agents Annual Revenue by Company (2020-2022)
3.2.1 Global Surgical Hemostatic Agents Revenue by Company (2020-2022)
3.2.2 Global Surgical Hemostatic Agents Revenue Market Share by Company (2020-2022)
3.3 Global Surgical Hemostatic Agents Sale Price by Company
3.4 Key Manufacturers Surgical Hemostatic Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Surgical Hemostatic Agents Product Location Distribution
3.4.2 Players Surgical Hemostatic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Surgical Hemostatic Agents by Geographic Region
4.1 World Historic Surgical Hemostatic Agents Market Size by Geographic Region (2017-2022)
4.1.1 Global Surgical Hemostatic Agents Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Surgical Hemostatic Agents Annual Revenue by Geographic Region
4.2 World Historic Surgical Hemostatic Agents Market Size by Country/Region (2017-2022)
4.2.1 Global Surgical Hemostatic Agents Annual Sales by Country/Region (2017-2022)
4.2.2 Global Surgical Hemostatic Agents Annual Revenue by Country/Region
4.3 Americas Surgical Hemostatic Agents Sales Growth
4.4 APAC Surgical Hemostatic Agents Sales Growth
4.5 Europe Surgical Hemostatic Agents Sales Growth
4.6 Middle East & Africa Surgical Hemostatic Agents Sales Growth
5 Americas
5.1 Americas Surgical Hemostatic Agents Sales by Country
5.1.1 Americas Surgical Hemostatic Agents Sales by Country (2017-2022)
5.1.2 Americas Surgical Hemostatic Agents Revenue by Country (2017-2022)
5.2 Americas Surgical Hemostatic Agents Sales by Type
5.3 Americas Surgical Hemostatic Agents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Surgical Hemostatic Agents Sales by Region
6.1.1 APAC Surgical Hemostatic Agents Sales by Region (2017-2022)
6.1.2 APAC Surgical Hemostatic Agents Revenue by Region (2017-2022)
6.2 APAC Surgical Hemostatic Agents Sales by Type
6.3 APAC Surgical Hemostatic Agents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Surgical Hemostatic Agents by Country
7.1.1 Europe Surgical Hemostatic Agents Sales by Country (2017-2022)
7.1.2 Europe Surgical Hemostatic Agents Revenue by Country (2017-2022)
7.2 Europe Surgical Hemostatic Agents Sales by Type
7.3 Europe Surgical Hemostatic Agents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Surgical Hemostatic Agents by Country
8.1.1 Middle East & Africa Surgical Hemostatic Agents Sales by Country (2017-2022)
8.1.2 Middle East & Africa Surgical Hemostatic Agents Revenue by Country (2017-2022)
8.2 Middle East & Africa Surgical Hemostatic Agents Sales by Type
8.3 Middle East & Africa Surgical Hemostatic Agents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Surgical Hemostatic Agents
10.3 Manufacturing Process Analysis of Surgical Hemostatic Agents
10.4 Industry Chain Structure of Surgical Hemostatic Agents
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Surgical Hemostatic Agents Distributors
11.3 Surgical Hemostatic Agents Customer
12 World Forecast Review for Surgical Hemostatic Agents by Geographic Region
12.1 Global Surgical Hemostatic Agents Market Size Forecast by Region
12.1.1 Global Surgical Hemostatic Agents Forecast by Region (2023-2028)
12.1.2 Global Surgical Hemostatic Agents Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Surgical Hemostatic Agents Forecast by Type
12.7 Global Surgical Hemostatic Agents Forecast by Application
13 Key Players Analysis
13.1 J&J
13.1.1 J&J Company Information
13.1.2 J&J Surgical Hemostatic Agents Product Offered
13.1.3 J&J Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 J&J Main Business Overview
13.1.5 J&J Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Surgical Hemostatic Agents Product Offered
13.2.3 Baxter Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Surgical Hemostatic Agents Product Offered
13.3.3 BD Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Gelita
13.4.1 Gelita Company Information
13.4.2 Gelita Surgical Hemostatic Agents Product Offered
13.4.3 Gelita Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Gelita Main Business Overview
13.4.5 Gelita Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Surgical Hemostatic Agents Product Offered
13.5.3 Pfizer Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 B Braun
13.6.1 B Braun Company Information
13.6.2 B Braun Surgical Hemostatic Agents Product Offered
13.6.3 B Braun Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 B Braun Main Business Overview
13.6.5 B Braun Latest Developments
13.7 CSL Behring
13.7.1 CSL Behring Company Information
13.7.2 CSL Behring Surgical Hemostatic Agents Product Offered
13.7.3 CSL Behring Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CSL Behring Main Business Overview
13.7.5 CSL Behring Latest Developments
13.8 Ferrosan Medical Devices
13.8.1 Ferrosan Medical Devices Company Information
13.8.2 Ferrosan Medical Devices Surgical Hemostatic Agents Product Offered
13.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ferrosan Medical Devices Main Business Overview
13.8.5 Ferrosan Medical Devices Latest Developments
13.9 Advance Medical Solution
13.9.1 Advance Medical Solution Company Information
13.9.2 Advance Medical Solution Surgical Hemostatic Agents Product Offered
13.9.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Advance Medical Solution Main Business Overview
13.9.5 Advance Medical Solution Latest Developments
13.10 Medtronic
13.10.1 Medtronic Company Information
13.10.2 Medtronic Surgical Hemostatic Agents Product Offered
13.10.3 Medtronic Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Medtronic Main Business Overview
13.10.5 Medtronic Latest Developments
13.11 Z-Medica
13.11.1 Z-Medica Company Information
13.11.2 Z-Medica Surgical Hemostatic Agents Product Offered
13.11.3 Z-Medica Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Z-Medica Main Business Overview
13.11.5 Z-Medica Latest Developments
13.12 Marine Polymer
13.12.1 Marine Polymer Company Information
13.12.2 Marine Polymer Surgical Hemostatic Agents Product Offered
13.12.3 Marine Polymer Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Marine Polymer Main Business Overview
13.12.5 Marine Polymer Latest Developments
13.13 Equimedical
13.13.1 Equimedical Company Information
13.13.2 Equimedical Surgical Hemostatic Agents Product Offered
13.13.3 Equimedical Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Equimedical Main Business Overview
13.13.5 Equimedical Latest Developments
13.14 CryoLife
13.14.1 CryoLife Company Information
13.14.2 CryoLife Surgical Hemostatic Agents Product Offered
13.14.3 CryoLife Surgical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 CryoLife Main Business Overview
13.14.5 CryoLife Latest Developments
14 Research Findings and Conclusion
Table 1. Surgical Hemostatic Agents Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Surgical Hemostatic Agents Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Gelation Hemostats
Table 4. Major Players of Combination Hemostats
Table 5. Major Players of Others
Table 6. Global Surgical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
Table 7. Global Surgical Hemostatic Agents Sales Market Share by Type (2017-2022)
Table 8. Global Surgical Hemostatic Agents Revenue by Type (2017-2022) & ($ million)
Table 9. Global Surgical Hemostatic Agents Revenue Market Share by Type (2017-2022)
Table 10. Global Surgical Hemostatic Agents Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Surgical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
Table 12. Global Surgical Hemostatic Agents Sales Market Share by Application (2017-2022)
Table 13. Global Surgical Hemostatic Agents Revenue by Application (2017-2022)
Table 14. Global Surgical Hemostatic Agents Revenue Market Share by Application (2017-2022)
Table 15. Global Surgical Hemostatic Agents Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Surgical Hemostatic Agents Sales by Company (2020-2022) & (K Units)
Table 17. Global Surgical Hemostatic Agents Sales Market Share by Company (2020-2022)
Table 18. Global Surgical Hemostatic Agents Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Surgical Hemostatic Agents Revenue Market Share by Company (2020-2022)
Table 20. Global Surgical Hemostatic Agents Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Surgical Hemostatic Agents Producing Area Distribution and Sales Area
Table 22. Players Surgical Hemostatic Agents Products Offered
Table 23. Surgical Hemostatic Agents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Surgical Hemostatic Agents Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Surgical Hemostatic Agents Sales Market Share Geographic Region (2017-2022)
Table 28. Global Surgical Hemostatic Agents Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Surgical Hemostatic Agents Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Surgical Hemostatic Agents Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Surgical Hemostatic Agents Sales Market Share by Country/Region (2017-2022)
Table 32. Global Surgical Hemostatic Agents Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Surgical Hemostatic Agents Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Surgical Hemostatic Agents Sales by Country (2017-2022) & (K Units)
Table 35. Americas Surgical Hemostatic Agents Sales Market Share by Country (2017-2022)
Table 36. Americas Surgical Hemostatic Agents Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Surgical Hemostatic Agents Revenue Market Share by Country (2017-2022)
Table 38. Americas Surgical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
Table 39. Americas Surgical Hemostatic Agents Sales Market Share by Type (2017-2022)
Table 40. Americas Surgical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
Table 41. Americas Surgical Hemostatic Agents Sales Market Share by Application (2017-2022)
Table 42. APAC Surgical Hemostatic Agents Sales by Region (2017-2022) & (K Units)
Table 43. APAC Surgical Hemostatic Agents Sales Market Share by Region (2017-2022)
Table 44. APAC Surgical Hemostatic Agents Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Surgical Hemostatic Agents Revenue Market Share by Region (2017-2022)
Table 46. APAC Surgical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
Table 47. APAC Surgical Hemostatic Agents Sales Market Share by Type (2017-2022)
Table 48. APAC Surgical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
Table 49. APAC Surgical Hemostatic Agents Sales Market Share by Application (2017-2022)
Table 50. Europe Surgical Hemostatic Agents Sales by Country (2017-2022) & (K Units)
Table 51. Europe Surgical Hemostatic Agents Sales Market Share by Country (2017-2022)
Table 52. Europe Surgical Hemostatic Agents Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Surgical Hemostatic Agents Revenue Market Share by Country (2017-2022)
Table 54. Europe Surgical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
Table 55. Europe Surgical Hemostatic Agents Sales Market Share by Type (2017-2022)
Table 56. Europe Surgical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
Table 57. Europe Surgical Hemostatic Agents Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Surgical Hemostatic Agents Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Surgical Hemostatic Agents Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Surgical Hemostatic Agents Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Surgical Hemostatic Agents Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Surgical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Surgical Hemostatic Agents Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Surgical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Surgical Hemostatic Agents Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Surgical Hemostatic Agents
Table 67. Key Market Challenges & Risks of Surgical Hemostatic Agents
Table 68. Key Industry Trends of Surgical Hemostatic Agents
Table 69. Surgical Hemostatic Agents Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Surgical Hemostatic Agents Distributors List
Table 72. Surgical Hemostatic Agents Customer List
Table 73. Global Surgical Hemostatic Agents Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Surgical Hemostatic Agents Sales Market Forecast by Region
Table 75. Global Surgical Hemostatic Agents Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Surgical Hemostatic Agents Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Surgical Hemostatic Agents Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Surgical Hemostatic Agents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Surgical Hemostatic Agents Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Surgical Hemostatic Agents Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Surgical Hemostatic Agents Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Surgical Hemostatic Agents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Surgical Hemostatic Agents Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Surgical Hemostatic Agents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Surgical Hemostatic Agents Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Surgical Hemostatic Agents Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Surgical Hemostatic Agents Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Surgical Hemostatic Agents Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Surgical Hemostatic Agents Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Surgical Hemostatic Agents Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Surgical Hemostatic Agents Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Surgical Hemostatic Agents Revenue Market Share Forecast by Application (2023-2028)
Table 93. J&J Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 94. J&J Surgical Hemostatic Agents Product Offered
Table 95. J&J Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. J&J Main Business
Table 97. J&J Latest Developments
Table 98. Baxter Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 99. Baxter Surgical Hemostatic Agents Product Offered
Table 100. Baxter Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Baxter Main Business
Table 102. Baxter Latest Developments
Table 103. BD Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 104. BD Surgical Hemostatic Agents Product Offered
Table 105. BD Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. BD Main Business
Table 107. BD Latest Developments
Table 108. Gelita Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 109. Gelita Surgical Hemostatic Agents Product Offered
Table 110. Gelita Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Gelita Main Business
Table 112. Gelita Latest Developments
Table 113. Pfizer Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Surgical Hemostatic Agents Product Offered
Table 115. Pfizer Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. B Braun Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 119. B Braun Surgical Hemostatic Agents Product Offered
Table 120. B Braun Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. B Braun Main Business
Table 122. B Braun Latest Developments
Table 123. CSL Behring Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 124. CSL Behring Surgical Hemostatic Agents Product Offered
Table 125. CSL Behring Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. CSL Behring Main Business
Table 127. CSL Behring Latest Developments
Table 128. Ferrosan Medical Devices Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 129. Ferrosan Medical Devices Surgical Hemostatic Agents Product Offered
Table 130. Ferrosan Medical Devices Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Ferrosan Medical Devices Main Business
Table 132. Ferrosan Medical Devices Latest Developments
Table 133. Advance Medical Solution Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 134. Advance Medical Solution Surgical Hemostatic Agents Product Offered
Table 135. Advance Medical Solution Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Advance Medical Solution Main Business
Table 137. Advance Medical Solution Latest Developments
Table 138. Medtronic Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 139. Medtronic Surgical Hemostatic Agents Product Offered
Table 140. Medtronic Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Medtronic Main Business
Table 142. Medtronic Latest Developments
Table 143. Z-Medica Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 144. Z-Medica Surgical Hemostatic Agents Product Offered
Table 145. Z-Medica Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Z-Medica Main Business
Table 147. Z-Medica Latest Developments
Table 148. Marine Polymer Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 149. Marine Polymer Surgical Hemostatic Agents Product Offered
Table 150. Marine Polymer Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Marine Polymer Main Business
Table 152. Marine Polymer Latest Developments
Table 153. Equimedical Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 154. Equimedical Surgical Hemostatic Agents Product Offered
Table 155. Equimedical Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Equimedical Main Business
Table 157. Equimedical Latest Developments
Table 158. CryoLife Basic Information, Surgical Hemostatic Agents Manufacturing Base, Sales Area and Its Competitors
Table 159. CryoLife Surgical Hemostatic Agents Product Offered
Table 160. CryoLife Surgical Hemostatic Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. CryoLife Main Business
Table 162. CryoLife Latest Developments
List of Figures
Figure 1. Picture of Surgical Hemostatic Agents
Figure 2. Surgical Hemostatic Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Surgical Hemostatic Agents Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Surgical Hemostatic Agents Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Surgical Hemostatic Agents Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Gelation Hemostats
Figure 10. Product Picture of Combination Hemostats
Figure 11. Product Picture of Others
Figure 12. Global Surgical Hemostatic Agents Sales Market Share by Type in 2021
Figure 13. Global Surgical Hemostatic Agents Revenue Market Share by Type (2017-2022)
Figure 14. Surgical Hemostatic Agents Consumed in Hospitals
Figure 15. Global Surgical Hemostatic Agents Market: Hospitals (2017-2022) & (K Units)
Figure 16. Surgical Hemostatic Agents Consumed in Surgical Centers
Figure 17. Global Surgical Hemostatic Agents Market: Surgical Centers (2017-2022) & (K Units)
Figure 18. Surgical Hemostatic Agents Consumed in Other
Figure 19. Global Surgical Hemostatic Agents Market: Other (2017-2022) & (K Units)
Figure 20. Global Surgical Hemostatic Agents Sales Market Share by Application (2017-2022)
Figure 21. Global Surgical Hemostatic Agents Revenue Market Share by Application in 2021
Figure 22. Surgical Hemostatic Agents Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Surgical Hemostatic Agents Revenue Market Share by Company in 2021
Figure 24. Global Surgical Hemostatic Agents Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Surgical Hemostatic Agents Revenue Market Share by Geographic Region in 2021
Figure 26. Global Surgical Hemostatic Agents Sales Market Share by Region (2017-2022)
Figure 27. Global Surgical Hemostatic Agents Revenue Market Share by Country/Region in 2021
Figure 28. Americas Surgical Hemostatic Agents Sales 2017-2022 (K Units)
Figure 29. Americas Surgical Hemostatic Agents Revenue 2017-2022 ($ Millions)
Figure 30. APAC Surgical Hemostatic Agents Sales 2017-2022 (K Units)
Figure 31. APAC Surgical Hemostatic Agents Revenue 2017-2022 ($ Millions)
Figure 32. Europe Surgical Hemostatic Agents Sales 2017-2022 (K Units)
Figure 33. Europe Surgical Hemostatic Agents Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Surgical Hemostatic Agents Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Surgical Hemostatic Agents Revenue 2017-2022 ($ Millions)
Figure 36. Americas Surgical Hemostatic Agents Sales Market Share by Country in 2021
Figure 37. Americas Surgical Hemostatic Agents Revenue Market Share by Country in 2021
Figure 38. United States Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Surgical Hemostatic Agents Sales Market Share by Region in 2021
Figure 43. APAC Surgical Hemostatic Agents Revenue Market Share by Regions in 2021
Figure 44. China Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Surgical Hemostatic Agents Sales Market Share by Country in 2021
Figure 51. Europe Surgical Hemostatic Agents Revenue Market Share by Country in 2021
Figure 52. Germany Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Surgical Hemostatic Agents Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Surgical Hemostatic Agents Revenue Market Share by Country in 2021
Figure 59. Egypt Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Surgical Hemostatic Agents Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Surgical Hemostatic Agents in 2021
Figure 65. Manufacturing Process Analysis of Surgical Hemostatic Agents
Figure 66. Industry Chain Structure of Surgical Hemostatic Agents
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...